from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1243c/PE_PGRS23

LFCtreatmentdescriptionclass of inhibitor

2.021

Amikacinug/mL Amikacintranslation

1.240

Cap5-10ug/mL Capreomycintranslation

1.869

Rox10-50 ug/mL Roxithromycintranslation

0.290

SM2-5 ug/mL Streptomycintranslation

2.140

Tet5-10 ug/mL Tetracyclinetranslation

-0.426

Rif0.2-5ug/mL Rifampicintranscription

-1.999

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.564

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.628

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.337

CPZ10-50 ug/mL Chlorpromazinerespiration

0.642

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.331

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.282

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.119

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.480

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.419

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.182

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.580

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.059

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.473

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.639

KCN5-20 ug/mL Potassium cyaniderespiration

0.158

NaN30.2-2 mM Sodium aziderespiration

0.404

Nigericin50 uM Nigericinrespiration

0.006

TRC10-150 ug/mL Triclosanrespiration

0.632

TRZ10-25 ug/mL Thioridazinerespiration

1.514

Valinomycin0.5-10 uM Valinomycinrespiration

-0.692

ZnSO42 mM ZnSO4respiration

-0.969

menadione6-10 ug/mL Menadionerespiration

0.224

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.699

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.373

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.581

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.373

NRP_1Non-replicating persistence stage 1dosRassociated

-0.048

Amp0.2mg/mL AmpicillincellWall

-0.320

Cephalexin20-100 ug/mL CephalexincellWall

-0.992

Cerulenin0.32-5 ug/mL CerulenincellWall

0.503

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.464

EMB10-20 ug/mL EthambutolcellWall

-0.576

Eta12-40 ug/mL EthionamidecellWall

0.061

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.910

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.132

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.205

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.201

BZA0.12 mg/mL BenzamidearomaticAmides

0.171

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.393

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.193

H2O24 mM hydrogen peroxideDNAdamaging

-0.274

Levo10 ug/mL LevofloxacinDNAdamaging

-0.604

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.872

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.169

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.292

UVUV-irradiationDNAdamaging

0.849

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.657

Antimycin12.5-50 ug/mL Antimycin A?

-1.261

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.933

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.658

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.677

PA8240.2-2 ug/mL PA-824?

1.119

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.019

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.647

Verapamil50 uM Verapamil?

-1.315

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.477

methoxatin10-20 ug/mL Methoxatin?